↓ Skip to main content

SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

Overview of attention for article published in Clinical and Translational Oncology, December 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs
1 blog
twitter
6 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
Published in
Clinical and Translational Oncology, December 2022
DOI 10.1007/s12094-022-02985-7
Pubmed ID
Authors

Maria Gonzalez-Cao, Teresa Puertolas, Clara Martinez-Vila, Cristina Carrera, Cayetana Maldonado Seral, Pedro Rodríguez-Jiménez, Silvia Sequero, Pablo Cerezuela-Fuentes, Rosa Feltes Ochoa, Eva Muñoz, Mónica Antoñanzas Basa, Juan Martín-Liberal, Ainara Soria, Juan Francisco Rodriguez Moreno, Ivan Marquez-Rodas, Pilar Lopez Criado, José Luis Manzano, Rafael Lopez-Castro, Pablo Ayala de Miguel, Laura Villalobos, Salvador Martin Algarra, Ines Gonzalez-Barrallo, Aram Boada, Almudena García Castaño, Susana Puig, Guillermo Crespo, Pablo Luna Fra, Cristina Aguayo Zamora, Marta Feito Rodríguez, Lara Valles, Ana Drozdowskyj, Jesús Gardeazabal, Luis Antonio Fernandez-Morales, Alberto Rodrigo, Raquel Cruz, Oriol Yelamos, Belen Rubio, Karmele Mujica, Mariano Provencio, Alfonso Berrocal

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 15%
Researcher 2 15%
Unspecified 1 8%
Student > Bachelor 1 8%
Unknown 7 54%
Readers by discipline Count As %
Chemical Engineering 1 8%
Unspecified 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Psychology 1 8%
Other 1 8%
Unknown 7 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2023.
All research outputs
#4,116,114
of 25,392,582 outputs
Outputs from Clinical and Translational Oncology
#163
of 1,464 outputs
Outputs of similar age
#79,811
of 477,475 outputs
Outputs of similar age from Clinical and Translational Oncology
#4
of 48 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,464 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 477,475 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.